<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36973">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107521</url>
  </required_header>
  <id_info>
    <org_study_id>Sapi IMSI IF</org_study_id>
    <nct_id>NCT02107521</nct_id>
  </id_info>
  <brief_title>IMSI in Couples With Previous Implantation Failures</brief_title>
  <official_title>The Effect of the Intracytoplasmic Morphologically Selected Sperm Injection in Couples With Previous Implantation Failure After Intracytoplasmic Sperm Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sapientiae Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sapientiae Institute</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a lack of clarity regarding the justification to instruct the couple to shift from
      intracytoplasmic sperm injection (ICSI) to intracytoplasmic morphologically selected sperm
      injection (IMSI). In this study, we aim at evaluating the efficacy of IMSI in couples with
      previous implantation failure with ICSI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Implantation</measure>
    <time_frame>4-5 weeks' gestation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The presence of a gestational sac with heart beat, visualized upon ultrasound scan at 4-5 weeks' gestation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">386</enrollment>
  <condition>Male Infertility</condition>
  <condition>Female Infertility</condition>
  <arm_group>
    <arm_group_label>ICSI group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, sperm selected for injection will be morphologically evaluated under 400x magnification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMSI group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group, sperm selected for injection will be morphologically evaluated under 6600x magnification</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intracytoplasmic morphologically selected sperm injection</intervention_name>
    <description>Sperm selection for injection will be performed at 6600x magnification</description>
    <arm_group_label>IMSI group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intracytoplasmic sperm injection</intervention_name>
    <description>sperm selection for injection will be performed under 400x magnification</description>
    <arm_group_label>ICSI group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ICSI indication, who have previously underwent &gt;= 1 ICSI attempt in
             which at least 2 blastocysts were transferred, with no implantation.

          -  Regular menstrual cycles every 25-35 days.

          -  Body Mass Index less than 35 as calculated according to the following formula: body
             weight (kg) / height x height (m2)

          -  Presence of both ovaries.

          -  No pelvic and / or clinically significant uterine anomalies.

          -  Normal cervical cytology.

          -  Serum follicle stimulating hormone (FSH) within normal limits.

        Exclusion Criteria:

          -  Clinically significant systemic disease.

          -  Infection by the human immunodeficiency virus (HIV).

          -  Infection by the by the hepatitis C virus

          -  Positive test for surface antigens of hepatitis B.

          -  Endometriosis stages III - IV (classification of the American Society for
             Reproductive Medicine).

          -  Hydrosalpinx, unilateral or bilateral.

          -  Abnormal gynecological bleeding, undiagnosed.

          -  Allergy or hypersensitivity to human gonadotropin preparations or any other related
             to the study medication.

        -Simultaneous participation in another clinical trial.  -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edson Borges, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sapientiae Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edson Borges Jr., PhD</last_name>
    <phone>551130188181</phone>
    <email>science@fertility.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fertility - Centro de Fertilização Assistida</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04503-040</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edson Borges, PhD</last_name>
      <phone>55113018818</phone>
      <email>science@sapientiae.org.br</email>
    </contact>
    <investigator>
      <last_name>Amanda S Raize, B.Sc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>April 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sperm morphology</keyword>
  <keyword>ICSI</keyword>
  <keyword>IMSI</keyword>
  <keyword>implantation</keyword>
  <keyword>pregnancy</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
